Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kilian V M Huber

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Nature Chemical Biology|January 20, 2017
Target engagement: Shining a lightKilian V M Huber
ACS Medicinal Chemistry Letters|April 16, 2020
Importance of Quantifying Drug-Target Engagement in CellsJakub Stefaniak, Kilian V M Huber
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2015
Profiling of Small Molecules by Chemical ProteomicsKilian V M Huber, Giulio Superti-Furga
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Global Assessment of Drug Target Engagement and Selectivity of Covalent Cysteine-Reactive Inhibitors Using Alkyne-Functionalized ProbesElisabeth M Rothweiler, Kilian V M Huber
Biological Chemistry|February 22, 2022
Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulatorsElisabeth M Rothweiler, Paul E Brennan, Kilian V M Huber
Expert Opinion on Drug Discovery|April 17, 2023
Open resources for chemical probes and their implications for future drug discoveryEsra Balıkçı, Anne-Sophie M C Marques, Jesper S Hansen, et al.
Expert Opinion on Drug Discovery|March 3, 2025
Drug repurposing in amyotrophic lateral sclerosis (ALS)Emily Carroll, Jakub Scaber, Kilian V M Huber, et al.
International Immunopharmacology|October 12, 2020
Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathwayElia Álvarez-Coiradas, Cristian R Munteanu, Laura Díaz-Sáez, et al.
ACS Chemical Biology|May 9, 2014
Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomicsPiero Giansanti, Christian Preisinger, Kilian V M Huber, et al.
Cell Reports|October 26, 2022
DNA double-strand break-derived RNA drives TIRR/53BP1 complex dissociationRuth F Ketley, Federica Battistini, Adele Alagia, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Nature Chemical Biology|January 20, 2017
Target engagement: Shining a lightKilian V M Huber
ACS Medicinal Chemistry Letters|April 16, 2020
Importance of Quantifying Drug-Target Engagement in CellsJakub Stefaniak, Kilian V M Huber
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2015
Profiling of Small Molecules by Chemical ProteomicsKilian V M Huber, Giulio Superti-Furga
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Global Assessment of Drug Target Engagement and Selectivity of Covalent Cysteine-Reactive Inhibitors Using Alkyne-Functionalized ProbesElisabeth M Rothweiler, Kilian V M Huber
Biological Chemistry|February 22, 2022
Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulatorsElisabeth M Rothweiler, Paul E Brennan, Kilian V M Huber
Expert Opinion on Drug Discovery|April 17, 2023
Open resources for chemical probes and their implications for future drug discoveryEsra Balıkçı, Anne-Sophie M C Marques, Jesper S Hansen, et al.
Expert Opinion on Drug Discovery|March 3, 2025
Drug repurposing in amyotrophic lateral sclerosis (ALS)Emily Carroll, Jakub Scaber, Kilian V M Huber, et al.
International Immunopharmacology|October 12, 2020
Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathwayElia Álvarez-Coiradas, Cristian R Munteanu, Laura Díaz-Sáez, et al.
ACS Chemical Biology|May 9, 2014
Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomicsPiero Giansanti, Christian Preisinger, Kilian V M Huber, et al.
Cell Reports|October 26, 2022
DNA double-strand break-derived RNA drives TIRR/53BP1 complex dissociationRuth F Ketley, Federica Battistini, Adele Alagia, et al.
Pageof 6